In their subsequent paper, the authors, using bisulfite genomic sequencing, revealed that this previously unidentified subset of AML was represented by samples where CEBPA gene promoter was hypermethylated [129]. The gene discussed is CEBPA; the disease is acute myeloid leukemia.